Caxton Associates (UK)’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-57,237
Closed -$232K – 809
2025
Q3
$232K Sell
57,237
-21,770
-28% -$86.9K 0.01% 606
2025
Q2
$308K Buy
+79,007
New +$249K 0.01% 544

Other funds holding DH

Caxton Associates (UK)'s DH Position: Q4 2025 in Review

Caxton Associates (UK) sold out of Definitive Healthcare (DH) in Q4 2025, closing a stake of 57,237 shares — an estimated $232K sold.

Caxton Associates (UK) first reported a position in DH in Q2 2025 and held it in 2 quarters. The position peaked at $308K in Q2 2025. 122 funds tracked by Wall St. Rank hold DH as of Q4 2025.

  • Caxton Associates (UK) reported no remaining Definitive Healthcare position as of Q4 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 57,237 Definitive Healthcare shares in Q4 2025, an estimated $232K.
  • Caxton Associates (UK) first reported a position in Definitive Healthcare in Q2 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Definitive Healthcare position peaked at $308K in Q2 2025.
  • 122 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2025.

Based on Caxton Associates (UK)'s 13F filing for Q4 2025, filed 13 Feb 2026.